Pfizer Korea unveils Norvasc ODT

Pfizer Korea, a Korean unit of the U.S. based Pfizer Inc., said Tuesday it has started selling the oral disintegrating tablets (5 mg, 10 mg) of Norvasc (amlodipine besylate) here, adding another dosage form to its Norvasc line-up. The new dosage form is now available in Japan.

The most popular solid dosage forms are being tablets and capsules, one important drawback of these dosage form for ...